The Veterinary Cancer Center

The VCC's 1st Annual VetOlympics

Veterinarians and the staff of local hospitals are invited to send their best to compete for pride and for glory in the 1st Annual VetOlympics. This interactive and intellectual event will consist of teams of five, and can have more than one team per hospital.

This will be an evening of fun, food, drink, laughter, team building and friendly competition. In the end, however, only one hospital shall stand victorious and hold yearly rights to the coveted 1st Annual VetOlympics Trophy. Awards, trophies and prizes shall also be given based on team spirit, best team uniform and more!

Medical Oncologist Wanted

The Veterinary Cancer Center (VCC) ( is seeking a board-certified or residency trained medical oncologist for a Long Island Comprehensive Cancer Center as well as at location in East End Veterinary Center, NY, Red Bank Veterinary Hospital: Hillsborough, NJ, Red Bank Veterinary Hospital: Mount Laurel, NJ, VRC, PA.

Stereotactic radiation (SRT) & Intensity Modulated Radiation Therapy (IMRT)

Stereotactic radiation (SRT) and Intensity Modulated Radiation Therapy (IMRT) are becoming more readily available for animals. In the past, traditional radiation therapy to treat cancer in pets would usually result in significant side effects and many owners would decide not to pursue treatment because of this. IMRT and SRT are changing the way that we are able to treat cancer in pets, and they have great potential to improve both your pet’s quality and quantity of life. The Veterinary Cancer Center is pleased to be able to offer these treatments for pets with cancer.

Emotionally Hijacked by Cancer

David & Cody

One of the biggest challenges The Veterinary Cancer Center staff face in treating cancer is that the general public assumes that cancer treatment is the same in people and pets. Witnessing a friend or a family member undergoing cancer treatment, even watching a TV episode of “House”, the most optimistic person is aware of the host of side effects experienced by human cancer patients. Pet owners, already emotionally spinning from the diagnosis of cancer in their pets, approach the veterinary oncology specialist with preconceived, inaccurate assumptions about cancer treatment in pets.

Dr. Post's on Animal Radio

Consider Giving Hope This Year to a Pet in Need

Dear fellow Animal Lover, Everyone who walks into this practice loves their pet, of that we are sure. Despite this, some pet parents do not have the resources to treat their beloved pets. The Veterinary Cancer Center has been a major supporter of a non-profit organization called the Riedel & Cody Fund. This 501(c)3 organization enables pets whose owners cannot afford cancer therapy to receive treatment. The Riedel and Cody Fund has already helped hundreds of pets and pet parents around the country.

Steven Bonell, MBA, MHA

As of September 17, 2015 Steven Bonell is no longer employed in the position of Hospital Administrator at The Veterinary Cancer Center. If you have any questions, concerns or need to contact The Veterinary Cancer Center please contact David Duchemin or Dr. Gerald S. Post at 203-838-6626. If you prefer email you may reach us at

Steven Bonell, MBA, MHA

Hospital Administrator


Update on Treatment of Canine Transitional Cell Carcinoma

Transitional cell carcinomas (TCCs) are the most common tumors of the urinary bladder.  The Scottish Terrier, Sheltie and Beagle are breeds with a higher risk factor for developing this cancer.  Other factors have been associated with a higher risk of development, including female gender, obesity and exposure to chemical lawn pesticides.1 Transitional cell carcinomas are typically very aggressive and invasive tumors associated with a moderate rate of metastasis.

Breakthrough Canine Cancer Vaccine Clinical Trial

Published: August 19, 2015, 5:48 pm | Updated: August 19, 2015, 7:33 pm

Innogenics —Genomic Profiling for Pets: What information can it provide

Innogenics is a specialty genomics reference laboratory that helps veterinarians and owners of pets with cancer by providing state-of-the-art molecular diagnostic analysis of tumor tissue at costs affordable to the pet owner. We provide a molecular profile of a dog’s tumor that details the cancer type and subtype and provides biomarker information useful in guiding decisions about current and novel therapeutic options.